Local wound care and topical management of hidradenitis suppurativa

Afsaneh Alavi, Robert Kirsner

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Hidradenitis suppurativa (HS) is a chronic, recurrent, debilitating disease predominantly involving apocrine gland-bearing skin. The folliculoinfundibular dysfunction and an aberrant cutaneous immune response to commensal bacteria are recognized as potential contributors. Topical antibiotics, such as clindamycin, and keratolytic agents have been used in the management of early stages of HS. Proper wound care is a key part of management, particularly in patients with advanced HS. The evidence for the optimal topical therapy or optimal local wound care is limited. As such, a multidisciplinary approach is necessary to address all aspects of HS, including topical therapy, systemic therapy, and proper wound care. The focus of this paper is to review the evidence for the topical management and local wound care strategies in patients with HS.

Original languageEnglish (US)
Pages (from-to)S55-S61
JournalJournal of the American Academy of Dermatology
Issue number5
StatePublished - Nov 1 2015


  • Clindamycin
  • Hidradenitis suppurativa
  • NPWT
  • Resorcinol
  • Retinoid
  • Topical treatments

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Local wound care and topical management of hidradenitis suppurativa'. Together they form a unique fingerprint.

Cite this